PROAIR DIGIHALER

Albuterol

PROAIR DIGIHALER

SABA MDI

Albuterol sulfate · Teva Pharmaceuticals

Clinical Reference

Active Medication & Mechanism

Albuterol sulfate SABA
90 mcg albuterol per inhalation

Short-acting beta2-adrenergic agonist. Activates beta2-receptors on airway smooth muscle, increasing intracellular cAMP and producing rapid bronchodilation (onset 5–15 minutes, duration 4–6 hours).

FDA-Approved Dosing by Indication

// approval varies by strength + age

Asthma

1/1 approved regimens

Strength	Population	Dose & Frequency	Total Daily	Status
90 mcg	Patients ≥4 years	2 inhalations every 4–6 hours as needed Treatment or prevention of bronchospasm in patients ≥4 years with reversible obstructive airway disease.	As needed; 1 inhalation may suffice in some patients	FDA Approved

90 mcg FDA Approved

Pop · Patients ≥4 years

2 inhalations every 4–6 hours as needed

Treatment or prevention of bronchospasm in patients ≥4 years with reversible obstructive airway disease.

Total · As needed; 1 inhalation may suffice in some patients

Exercise-Induced Bronchospasm

1/1 approved regimens

Strength	Population	Dose & Frequency	Total Daily	Status
90 mcg	Patients ≥4 years	2 inhalations 15–30 minutes before exercise Prevention of exercise-induced bronchospasm.	As needed	FDA Approved

90 mcg FDA Approved

Pop · Patients ≥4 years

2 inhalations 15–30 minutes before exercise

Prevention of exercise-induced bronchospasm.

Total · As needed